News
Piramal Pharma reports consolidated net loss of Rs 69.39 crore in the June 2026 quarter
30-Jul-2026 | 07:32
Sales rise 17.39% to Rs 2269.92 crore
Net Loss of Piramal Pharma reported to Rs 69.39 crore in the quarter ended June 2026 as against net loss of Rs 81.70 crore during the previous quarter ended June 2025. Sales rose 17.39% to Rs 2269.92 crore in the quarter ended June 2026 as against Rs 1933.71 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 2269.92 | 1933.71 | 17 |
| OPM % | 8.60 | 5.52 | - |
| PBDT | 216.09 | 97.52 | 122 |
| PBT | -7.46 | -99.76 | 93 |
| NP | -69.39 | -81.70 | 15 |
Powered by Capital Market - Live News